Trials of Deep TMS treatment by Israel’s Brainsway at Sheba Medical Center have shown a 27 percent improvement in patients with Obsessive Compulsive Disorder. These were OCD patients that had previously failed to respond to both pharmacological and psychological therapy. … Continue reading →

The US FDA has extended its approval of the Deep Transcranial Magnetic Stimulation system from Israel’s BrainsWay (see here previously). It can now be used to treat depression up to the patient’s 86th birthday. The previous maximum age limit was … Continue reading →

Israel’s BrainsWay’s has published another positive study of 247 depression patients receiving its Deep Transcranial Magnetic Stimulation treatment. 60% went into remission and 80% had a positive response. The results confirmed a 2023 study of 1,350 patients. https://www.brainsway.com/news_events/brainsway-announces-positive-results-in-late-life-depression-post-marketing-analysis/

Some 8 years ago (see here) the US Navy bought several Deep TMS therapy helmets made by Israel’s Brainsway to treat service personnel with PTSD and other conditions. The US military will now provide them to soldiers and veterans for … Continue reading →

Israel’s BrainsWay (see here previously) has received US FDA clearance for its 3-minute Theta Burst treatment protocol for Major Depressive Disorder (MDD). Patients demonstrate meaningful reduction in depression scores after the treatment. https://www.brainsway.com/news_events/brainsway-receives-fda-clearance-for-three-minute-theta-burst-treatment-protocol-for-major-depressive-disorder/

Israel’s BrainsWay (reported here previously) is now using its transcranial magnetic stimulation (TMS) technology to treat patients suffering with depression due to Covid. It is focusing on those struggling with recovery, who have lost loved ones, in financial difficulties etc. … Continue reading →

The US FDA has approved the use of the Deep Transcranial Magnetic Stimulation (TMS) system from Israel’s BrainsWay (see here) to treat cigarette smokers who seek to quit. The patient wears a helmet containing a patented H-coil that generates a … Continue reading →

Israeli companies HeartBeat Technologies and Brainsway have been selected for a joint Israel-Canada partnership program. They will test their innovative aging and brain health solutions at two Canadian seniors care organizations. https://globenewswire.com/news-release/2018/01/08/1285341/0/en/Two-Israeli-Firms-Selected-to-Test-Their-Aging-and-Brain-Health-Innovations-at-Ontario-Seniors-Care-Organizations.html http://www.heartbeattec.com/ https://israelactive.com/?s=Brainsway